TP53 Mutations in Chagasic Megaesophagus

Area of Science:

• Oncology
• Genetics
• Gastroenterology

Background:

• Chagasic megaesophagus (CME) significantly elevates esophageal carcinoma risk.
• The TP53 tumor suppressor gene is frequently implicated in various cancers.
• Investigating TP53 mutations in CME patients is crucial for understanding carcinogenesis.

Purpose of the Study:

• To identify and characterize mutations in the TP53 gene in patients with Chagas disease (CD), particularly those with CME.
• To explore the potential correlation between specific TP53 mutations and the presence of megaesophagus.
• To assess the preliminary association of these mutations with an increased risk of esophageal cancer.

Main Methods:

• Blood samples from 114 Chagas disease patients were analyzed.
• Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) was employed.
• DNA sequencing was performed on exons 5 and 7 of the TP53 gene.

Main Results:

• Mutations in exon 5 at codon 184 (GAT > AAT) were detected in 14.8% of G1, 10% of G2, and 5% of G3 patients.
• Mutations at exon 5 codon 185 (AGC > AGG) were observed in 14.8% of G1, 10% of G2, and 7.5% of G3 patients.
• A mutation in the intronic region of exon 7 (G > T) was found in 2.7% of G1 and 7.5% of G2 patients.

Conclusions:

• This study reports, for the first time, simultaneous TP53 gene mutations at codons 184 and 185 in patients with CME and Chagasic patients without megaesophagus.
• The findings suggest a potential role for these specific TP53 mutations in the pathogenesis of esophageal conditions in Chagas disease.
• Further extensive research is warranted to determine if the co-occurrence of mutations at codons 184 and 185 elevates the risk of esophageal carcinoma in this patient cohort.